Getting CD19 Into Shape: Expression of Natively Folded “Difficult-to- Express” CD19 for Staining and Stimulation of CAR-T Cells

The transmembrane protein CD19 is exclusively expressed on normal and malignant B cells and therefore constitutes the target of approved CAR-T cell-based cancer immunotherapies. Current efforts to assess CAR-T cell functionality in a quantitative fashion both in vitro and in vivo are hampered by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobner, Elisabeth, Wachernig, Anna, Gudipati, Venugopal, Mayrhofer, Patrick, Salzer, Benjamin, Lehner, Manfred, Huppa, Johannes B., Kunert, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020774/
https://www.ncbi.nlm.nih.gov/pubmed/32117929
http://dx.doi.org/10.3389/fbioe.2020.00049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020774/
https://www.ncbi.nlm.nih.gov/pubmed/32117929
http://dx.doi.org/10.3389/fbioe.2020.00049

Ejemplares similares